EPAM Systems is a global IT services firm with a focus on platform engineering, software development, and consulting services... Show more
EPAM Systems stock has experienced heightened volatility in recent trading sessions, reflecting mixed investor reactions to robust year-end performance juxtaposed against tempered forward guidance. Trading near the lower end of its 52-week range, the shares have underperformed broader indices over the past year amid sector headwinds in IT services. However, pockets of strength emerge from accelerating AI-native engagements and strategic expansions, positioning the company to capitalize on digital transformation demand. Analyst sentiment leans cautiously optimistic, with price targets suggesting meaningful upside potential as macroeconomic conditions stabilize and AI initiatives mature. Investors remain focused on execution amid evolving client priorities and competitive dynamics.
Tickeron’s Trending AI Robots page showcases a curated selection of over 25 high-performing AI trading bots designed for copy trading across dynamic stock market conditions. While Tickeron offers hundreds of AI Trading Bots that analyze and trade thousands of tickers using diverse strategies—from short-term momentum plays on 5-minute charts to longer-term sector rotations on hourly timeframes—only the most promising ones earn a spot in this elite section. These bots demonstrate impressive stats, such as annualized returns up to +251%, win rates ranging from 69% to 95%, profit factors exceeding 2.5, and low drawdowns, often outperforming the S&P 500 in recent months. Covering sectors like semiconductors, aerospace, infrastructure, biotech, and ETFs, they adapt to volatility with varying risk profiles and time horizons. Explore these top performers to enhance your trading edge by visiting the Trending AI Robots page and consider subscribing to those aligning with your strategy.
EPAM Systems, a global leader in digital platform engineering and software development, has navigated a turbulent period marked by solid operational results overshadowed by conservative forward guidance. On February 19, 2026, the company released Q4 and full-year 2025 earnings, posting revenue of $1.408 billion for the quarter—up 12.8% year-over-year and surpassing consensus estimates of $1.39 billion—and non-GAAP diluted EPS of $3.26, exceeding forecasts by 3.2%. Full-year revenue reached $5.457 billion, a 15.4% increase, driven by strong demand in financial services, healthcare, and emerging verticals. GAAP operating margins stood at 10.6% for Q4, with non-GAAP at 16.3%.
Despite the beat, shares plunged more than 16% in premarket trading the next day, extending to a weekly decline amid disappointment over 2026 guidance. Management projected full-year revenue growth of 4.5% to 7.5% (organic constant currency: 3% to 6%), with Q1 revenue at $1.385-1.400 billion. Non-GAAP operating margins are expected at 15-16%, reflecting pressures from elevated compensation, AI investments, and a one-point drag from a major Neoris client in Mexico facing economic headwinds like U.S. tariffs. CEO Balazs Fejes emphasized scaling AI-native revenues, noting hundreds of projects transitioning from pilots to full programs.
Earlier in February, EPAM expanded its AI-native agency, Empathy Lab, to North America following a European rollout. Led by industry veteran Ben Hall, the initiative targets CMOs seeking AI-powered platforms blending human insight with technology for marketing transformation, underscoring EPAM's pivot toward high-growth AI services projected to exceed $600 million in 2026 revenues. This built on prior AI momentum but did little to offset guidance concerns.
Analyst reactions amplified the sell-off. Morgan Stanley cut its price target to $160 from $175 (Equal Weight), TD Cowen to $220 from $243, Truist to $146 from $220, and Citigroup to $155 (Neutral), citing conservatism in the outlook. However, consensus targets hover around $195, implying over 35% upside from recent levels near $141. EPAM also repurchased 1.16 million shares for $223.5 million in Q4, part of a $660 million annual program with $776 million remaining, bolstering shareholder value amid the dip. Macro factors like prolonged IT spending scrutiny and geopolitical tensions further tempered sentiment, though EPAM's $1.3 billion cash position supports M&A and buybacks. Overall, price action linked directly to the guidance miss on organic growth expectations, despite AI tailwinds and earnings strength.
As EPAM enters 2026, focus shifts to executing its AI-native strategy amid moderated growth projections. Revenue guidance of 4.5-7.5% reflects transitory headwinds like client-specific softness and longer sales cycles for complex AI programs, but opportunities abound in scaling AI services to over $600 million, building on hundreds of expanding pilots. Investors should track AI revenue acceleration, particularly from Empathy Lab's North American push and partnerships driving foundational AI capabilities like cloud modernization and data platforms.
Risks include margin compression from higher compensation and investments, geopolitical instability impacting operations, and competition in AI transformation services. Macroeconomic volatility, such as IT budget constraints and U.S. tariffs affecting key clients, could prolong organic growth challenges. Balanced against this, EPAM's strong liquidity ($1.3B cash), ongoing share repurchases, and potential M&A in AI/healthcare niches offer resilience. Key monitors: quarterly AI-native revenue traction, utilization rates, client retention in core verticals, and progress toward non-GAAP EPS of $12.60-12.90. Success hinges on converting AI hype into measurable ROI for clients while navigating cost pressures.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
EPAM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 44 cases where EPAM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where EPAM's RSI Indicator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for EPAM just turned positive on May 19, 2026. Looking at past instances where EPAM's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EPAM advanced for three days, in of 325 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on June 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EPAM as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EPAM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for EPAM entered a downward trend on May 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.452) is normal, around the industry mean (7.300). P/E Ratio (13.704) is within average values for comparable stocks, (68.492). Projected Growth (PEG Ratio) (0.491) is also within normal values, averaging (1.077). EPAM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.027). P/S Ratio (0.952) is also within normal values, averaging (15.665).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. EPAM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EPAM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of software engineering solutions and technology services
Industry InformationTechnologyServices